• Je něco špatně v tomto záznamu ?

Identification of and discrimination between the Mycobacterium abscessus complex and Mycobacterium avium complex directly from sputum using quadruplex real-time PCR

R. Dziedzinska, J. Okunkova, P. Kralik, J. Svobodova, M. Mala, I. Slana

. 2022 ; 71 (12) : . [pub] -

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004915

Introduction. Cystic fibrosis (CF) is a serious disease with multisystemic clinical signs that is easily and frequently complicated by bacterial infection. Recently, the prevalence of nontuberculous mycobacteria as secondary contaminants of CF has increased, with the Mycobacterium avium complex (MAC) and Mycobacterium abscessus complex (MABSC) being the most frequently identified. The MABSC includes subspecies of significant clinical importance, mainly due to their resistance to antibiotics.Gap statement. Sensitive method for early detection and differentiation of MABSC members and MAC complex for use in routine clinical laboratories is lacking. A method based on direct DNA isolation from sputum, using standard equipment in clinical laboratories and allowing uncovering of possible sample inhibition (false negative results) would be required. The availability of such a method would allow accurate and accelerated time detection of MABSC members and their timely and targeted treatment.Aim. To develop a real time multiplex assay for rapid and sensitive identification and discrimination of MABSC members and MAC complex.Methodology. The method of DNA isolation directly from the sputum of patients followed by quadruplex real-time quantitative PCR (qPCR) detection was developed and optimised. The sensitivity and limit of detection (LOD) of the qPCR was determined using human sputum samples artificially spiked with a known amount of M. abscessus subsp. massiliense (MAM).Results. The method can distinguish between MAC and MABSC members and, at the same time, to differentiate between M. abscessus subsp. abscessus/subsp. bolletii (MAAb/MAB) and MAM. The system was verified using 61 culture isolates and sputum samples from CF and non-CF patients showing 29.5 % MAAb/MAB, 14.7 % MAM and 26.2 % MAC. The LOD was determined to be 1 490 MAM cells in the sputum sample with the efficiency of DNA isolation being 95.4 %. Verification of the qPCR results with sequencing showed 100 % homology.Conclusions. The developed quadruplex qPCR assay, which is preceded by DNA extraction directly from patients' sputum without the need for culturing, significantly improves and speeds up the entire process of diagnosing CF patients and is therefore particularly suitable for use in routine laboratories.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004915
003      
CZ-PrNML
005      
20230425171806.0
007      
ta
008      
230418s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1099/jmm.0.001611 $2 doi
035    __
$a (PubMed)36748608
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Dziedzinska, Radka $u Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Brno, Czechia
245    10
$a Identification of and discrimination between the Mycobacterium abscessus complex and Mycobacterium avium complex directly from sputum using quadruplex real-time PCR / $c R. Dziedzinska, J. Okunkova, P. Kralik, J. Svobodova, M. Mala, I. Slana
520    9_
$a Introduction. Cystic fibrosis (CF) is a serious disease with multisystemic clinical signs that is easily and frequently complicated by bacterial infection. Recently, the prevalence of nontuberculous mycobacteria as secondary contaminants of CF has increased, with the Mycobacterium avium complex (MAC) and Mycobacterium abscessus complex (MABSC) being the most frequently identified. The MABSC includes subspecies of significant clinical importance, mainly due to their resistance to antibiotics.Gap statement. Sensitive method for early detection and differentiation of MABSC members and MAC complex for use in routine clinical laboratories is lacking. A method based on direct DNA isolation from sputum, using standard equipment in clinical laboratories and allowing uncovering of possible sample inhibition (false negative results) would be required. The availability of such a method would allow accurate and accelerated time detection of MABSC members and their timely and targeted treatment.Aim. To develop a real time multiplex assay for rapid and sensitive identification and discrimination of MABSC members and MAC complex.Methodology. The method of DNA isolation directly from the sputum of patients followed by quadruplex real-time quantitative PCR (qPCR) detection was developed and optimised. The sensitivity and limit of detection (LOD) of the qPCR was determined using human sputum samples artificially spiked with a known amount of M. abscessus subsp. massiliense (MAM).Results. The method can distinguish between MAC and MABSC members and, at the same time, to differentiate between M. abscessus subsp. abscessus/subsp. bolletii (MAAb/MAB) and MAM. The system was verified using 61 culture isolates and sputum samples from CF and non-CF patients showing 29.5 % MAAb/MAB, 14.7 % MAM and 26.2 % MAC. The LOD was determined to be 1 490 MAM cells in the sputum sample with the efficiency of DNA isolation being 95.4 %. Verification of the qPCR results with sequencing showed 100 % homology.Conclusions. The developed quadruplex qPCR assay, which is preceded by DNA extraction directly from patients' sputum without the need for culturing, significantly improves and speeds up the entire process of diagnosing CF patients and is therefore particularly suitable for use in routine laboratories.
650    _2
$a lidé $7 D006801
650    _2
$a Mycobacterium avium komplex $x genetika $7 D015269
650    12
$a Mycobacterium abscessus $x genetika $7 D000073358
650    12
$a intracelulární infekce bakterií Mycobacterium avium $x epidemiologie $7 D015270
650    _2
$a kvantitativní polymerázová řetězová reakce $7 D060888
650    _2
$a sputum $x mikrobiologie $7 D013183
650    _2
$a netuberkulózní mykobakterie $7 D009170
650    12
$a cystická fibróza $x komplikace $x mikrobiologie $7 D003550
650    _2
$a DNA $x terapeutické užití $7 D004247
650    12
$a atypické mykobakteriální infekce $x diagnóza $x farmakoterapie $7 D009165
655    _2
$a časopisecké články $7 D016428
700    1_
$a Okunkova, Jana $u Microbiology and Antimicrobial Resistance, Veterinary Research Institute, Brno, Czechia
700    1_
$a Kralik, Petr $u Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Brno, Czechia
700    1_
$a Svobodova, Jana $u IFCOR - Klinické Laboratoře Ltd., Brno, Czechia
700    1_
$a Mala, Miriam $u Department of Pediatric Infectious Diseases, Centre of Cystic Fibrosis, University Hospital Brno, Brno, Czechia $u Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Slana, Iva $u Department of Animal Origin Food & Gastronomic Sciences, University of Veterinary Sciences Brno, Brno, Czechia
773    0_
$w MED00002792 $t Journal of medical microbiology $x 1473-5644 $g Roč. 71, č. 12 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36748608 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425171803 $b ABA008
999    __
$a ok $b bmc $g 1925167 $s 1191124
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 71 $c 12 $e - $i 1473-5644 $m Journal of Medical Microbiology $n J Med Microbiol $x MED00002792
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace